Arkolith/Insider Trading/ATRA/Form 4

Grant-Huerta Yanina

Chief Accounting OfficerAtara Biotherapeutics, Inc. (ATRA) · full profile →Form 4 · filed Aug 20, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$21K
Net Open-Market Flow
-$21K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2025Sell(S)55$11.61$63937K
Aug 18, 2025Sell(S)86$11.61$99837K
Aug 18, 2025Sell(S)2K$11.61$19K35K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-25-003069) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML